Therapeutic targets in subependymoma-Reference-Cited by-同舟云学术

Therapeutic targets in subependymoma

Published:2014-12 Issue:1-2 Volume:277 Page:168-175
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Kong Ling-Yuan,Wei Jun,Haider Ali S.,Liebelt Brandon D.^ORCID,Ling Xiaoyang,Conrad Charles A.^ORCID,Fuller Gregory N.,Levine Nicholas B.^ORCID,Priebe Waldemar,Sawaya Raymond,Heimberger Amy B.

Funder

Dr. Silverman Foundation

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference37 articles.

1. The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas;Abou-Ghazal;Clin. Cancer Res.,2008

2. The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells;Brooks;Invest. New Drugs,2007

3. The transcriptional network for mesenchymal transformation of brain tumours;Carro;Nature,2010

4. Berubicin: a novel topoisomerase II inhibitor with activity in ependymoma;Conrad,2009

5. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma;Doucette;Neuro-Oncol.,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraventricular Subependymoma With Obstructive Hydrocephalus: A Case Report and Literature Review;Cureus;2024-01-19

2. Intraoperative discovery of a radiographically occult subependymoma obstructing the obex in a patient with a Chiari malformation – A rare case;Surgical Neurology International;2024-01-05

3. Subependymomas of the fourth ventricle: To operate or not to operate?;Journal of Clinical Neuroscience;2023-12

4. Spinal Ependymomas: An Updated WHO Classification and a Narrative Review;Cureus;2023-11-20

5. Imaging characteristics of 4th ventricle subependymoma;Neuroradiology;2022-04-15